One breast cancer case had bi-allelic truncating variants in BARD1. The rest had truncating variants in BLM, ATM and ATRX. In addition, 30 other cases (27 breast cancer and 3 CRC) had in-frame or missense variants in 22 DSB genes (Additional file 6). This evidence concerns the gene BARD1 and breast carcinoma.